JP2018502867A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018502867A5 JP2018502867A5 JP2017536829A JP2017536829A JP2018502867A5 JP 2018502867 A5 JP2018502867 A5 JP 2018502867A5 JP 2017536829 A JP2017536829 A JP 2017536829A JP 2017536829 A JP2017536829 A JP 2017536829A JP 2018502867 A5 JP2018502867 A5 JP 2018502867A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- alkyl
- independently
- item
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(C)(c(cc1)ccc1OCCCN(C(CO)=C*)N)c(cc1I)ccc1OC[C@@](CCl)O Chemical compound CC(C)(c(cc1)ccc1OCCCN(C(CO)=C*)N)c(cc1I)ccc1OC[C@@](CCl)O 0.000 description 19
- XIAWGUMGQWOVAE-VARNECKGSA-N CC(C)(c(cc1)ccc1OC[C@@H](CN(/C(/I)=C(/CO)\N)N)O)c(cc1)cc(C)c1OC[C@H](CCl)O Chemical compound CC(C)(c(cc1)ccc1OC[C@@H](CN(/C(/I)=C(/CO)\N)N)O)c(cc1)cc(C)c1OC[C@H](CCl)O XIAWGUMGQWOVAE-VARNECKGSA-N 0.000 description 3
- XIAWGUMGQWOVAE-GYHWCHFESA-N CC(C)(c(cc1)ccc1OCC(CN(/C(/I)=C(/CO)\N)N)O)c(cc1)cc(C)c1OCC(CCl)O Chemical compound CC(C)(c(cc1)ccc1OCC(CN(/C(/I)=C(/CO)\N)N)O)c(cc1)cc(C)c1OCC(CCl)O XIAWGUMGQWOVAE-GYHWCHFESA-N 0.000 description 2
- YZVDXVDTKMNMRG-WOJBJXKFSA-N CC(C)(c(cc1)ccc1OC[C@@H](CN1NNC(CO)=C1I)O)c(cc1)cc(C)c1OC[C@@H](CCl)O Chemical compound CC(C)(c(cc1)ccc1OC[C@@H](CN1NNC(CO)=C1I)O)c(cc1)cc(C)c1OC[C@@H](CCl)O YZVDXVDTKMNMRG-WOJBJXKFSA-N 0.000 description 2
- JMKZHDMGGATWJW-OPGBNTAPSA-N CC(C)(c(cc1)cc(I)c1OC[C@@H](CN(/C(/C)=C(/CO)\NC)N)O)c(c(C)c1)ccc1OC[C@@H](CCl)O Chemical compound CC(C)(c(cc1)cc(I)c1OC[C@@H](CN(/C(/C)=C(/CO)\NC)N)O)c(c(C)c1)ccc1OC[C@@H](CCl)O JMKZHDMGGATWJW-OPGBNTAPSA-N 0.000 description 1
- CEBRWPXQQPYMGW-KQWNVCNZSA-N CC(C)(c(cc1)ccc1OCC(CCl)O)c(cc1)cc(I)c1OCC(CN(/C(/C)=C(/CO)\N)N)O Chemical compound CC(C)(c(cc1)ccc1OCC(CCl)O)c(cc1)cc(I)c1OCC(CN(/C(/C)=C(/CO)\N)N)O CEBRWPXQQPYMGW-KQWNVCNZSA-N 0.000 description 1
- NIZVBKKCQYUKAH-KQWNVCNZSA-N CC(C)(c(cc1)ccc1OCC(CN(/C(/CO)=C(/C)\N)N)O)c(cc1)cc(Cl)c1OCC(CCl)O Chemical compound CC(C)(c(cc1)ccc1OCC(CN(/C(/CO)=C(/C)\N)N)O)c(cc1)cc(Cl)c1OCC(CCl)O NIZVBKKCQYUKAH-KQWNVCNZSA-N 0.000 description 1
- QAGKXUTUMYBUHG-UHFFFAOYSA-N CC(C)(c(cc1)ccc1OCC(CN1CCSCC1)O)c(cc1)cc(C)c1OCC(CCl)O Chemical compound CC(C)(c(cc1)ccc1OCC(CN1CCSCC1)O)c(cc1)cc(C)c1OCC(CCl)O QAGKXUTUMYBUHG-UHFFFAOYSA-N 0.000 description 1
- BYSXMMVDVQIWHZ-OIBWEIMRSA-N CC(C)(c(cc1)ccc1OC[C@@H](CCl)O)c(cc1)cc(I)c1OC[C@H](CN(/C(/I)=C(/CO)\N)N)O Chemical compound CC(C)(c(cc1)ccc1OC[C@@H](CCl)O)c(cc1)cc(I)c1OC[C@H](CN(/C(/I)=C(/CO)\N)N)O BYSXMMVDVQIWHZ-OIBWEIMRSA-N 0.000 description 1
- NIZVBKKCQYUKAH-MKDPPFIESA-N CC(C)(c(cc1)ccc1OC[C@@H](CN(/C(/CO)=C(/C)\N)N)O)c(cc1)cc(Cl)c1OC[C@@H](CCl)O Chemical compound CC(C)(c(cc1)ccc1OC[C@@H](CN(/C(/CO)=C(/C)\N)N)O)c(cc1)cc(Cl)c1OC[C@@H](CCl)O NIZVBKKCQYUKAH-MKDPPFIESA-N 0.000 description 1
- KTARNTSTSZTHCT-OHBNSYPMSA-N CC(C)(c(cc1)ccc1OC[C@@H](CN(/C(/CO)=C\N)N)O)c(cc1)cc(I)c1OC[C@H](CCl)O Chemical compound CC(C)(c(cc1)ccc1OC[C@@H](CN(/C(/CO)=C\N)N)O)c(cc1)cc(I)c1OC[C@H](CCl)O KTARNTSTSZTHCT-OHBNSYPMSA-N 0.000 description 1
- XIAWGUMGQWOVAE-QCYQASIVSA-N CC(C)(c(cc1)ccc1OC[C@@H](CN(/C(/I)=C(/CO)\N)N)O)c(cc1)cc(C)c1OC[C@@H](CCl)O Chemical compound CC(C)(c(cc1)ccc1OC[C@@H](CN(/C(/I)=C(/CO)\N)N)O)c(cc1)cc(C)c1OC[C@@H](CCl)O XIAWGUMGQWOVAE-QCYQASIVSA-N 0.000 description 1
- POXJWKAJYJFOIV-BJKOFHAPSA-N CC(C)(c(cc1)ccc1OC[C@@H](CN1CCCCC1)O)c(cc1)cc(C)c1OC[C@H](CCl)O Chemical compound CC(C)(c(cc1)ccc1OC[C@@H](CN1CCCCC1)O)c(cc1)cc(C)c1OC[C@H](CCl)O POXJWKAJYJFOIV-BJKOFHAPSA-N 0.000 description 1
- SACYXVVIOQMRIL-DHIUTWEWSA-N CC(C)(c(cc1)ccc1OC[C@@H](CN1CCNCC1)O)c(cc1)cc(C)c1OC[C@@H](CCl)O Chemical compound CC(C)(c(cc1)ccc1OC[C@@H](CN1CCNCC1)O)c(cc1)cc(C)c1OC[C@@H](CCl)O SACYXVVIOQMRIL-DHIUTWEWSA-N 0.000 description 1
- QAGKXUTUMYBUHG-DHIUTWEWSA-N CC(C)(c(cc1)ccc1OC[C@@H](CN1CCSCC1)O)c(cc1)cc(C)c1OC[C@@H](CCl)O Chemical compound CC(C)(c(cc1)ccc1OC[C@@H](CN1CCSCC1)O)c(cc1)cc(C)c1OC[C@@H](CCl)O QAGKXUTUMYBUHG-DHIUTWEWSA-N 0.000 description 1
- WOWIDNHGEMHLSD-FGZHOGPDSA-N CC(C)(c(cc1)ccc1OC[C@@H](CN1NNC(C)=C1CO)O)c(cc1)cc(C)c1OC[C@@H](CCl)O Chemical compound CC(C)(c(cc1)ccc1OC[C@@H](CN1NNC(C)=C1CO)O)c(cc1)cc(C)c1OC[C@@H](CCl)O WOWIDNHGEMHLSD-FGZHOGPDSA-N 0.000 description 1
- CEBRWPXQQPYMGW-JFVMLZFZSA-N CC(C)(c(cc1)ccc1OC[C@H](CCl)O)c(cc1)cc(I)c1OC[C@H](CN(/C(/C)=C(/CO)\N)N)O Chemical compound CC(C)(c(cc1)ccc1OC[C@H](CCl)O)c(cc1)cc(I)c1OC[C@H](CN(/C(/C)=C(/CO)\N)N)O CEBRWPXQQPYMGW-JFVMLZFZSA-N 0.000 description 1
- NIZVBKKCQYUKAH-JFVMLZFZSA-N CC(C)(c(cc1)ccc1OC[C@H](CN(/C(/CO)=C(/C)\N)N)O)c(cc1)cc(Cl)c1OC[C@H](CCl)O Chemical compound CC(C)(c(cc1)ccc1OC[C@H](CN(/C(/CO)=C(/C)\N)N)O)c(cc1)cc(Cl)c1OC[C@H](CCl)O NIZVBKKCQYUKAH-JFVMLZFZSA-N 0.000 description 1
- RZCYGKPMEAXGJF-BXNYWHPCSA-N CC(C)(c(cc1)ccc1OC[C@H](CN(/C(/CO)=C(/C1C[IH]CC1)\N)N)O)c(cc1)cc(Cl)c1OC[C@@H](CCl)O Chemical compound CC(C)(c(cc1)ccc1OC[C@H](CN(/C(/CO)=C(/C1C[IH]CC1)\N)N)O)c(cc1)cc(Cl)c1OC[C@@H](CCl)O RZCYGKPMEAXGJF-BXNYWHPCSA-N 0.000 description 1
- XIAWGUMGQWOVAE-IPNNPURTSA-N CC(C)(c(cc1)ccc1OC[C@H](CN(/C(/I)=C(/CO)\N)N)O)c(cc1)cc(C)c1OC[C@@H](CCl)O Chemical compound CC(C)(c(cc1)ccc1OC[C@H](CN(/C(/I)=C(/CO)\N)N)O)c(cc1)cc(C)c1OC[C@@H](CCl)O XIAWGUMGQWOVAE-IPNNPURTSA-N 0.000 description 1
- XIAWGUMGQWOVAE-FHXNKAKFSA-N CC(C)(c(cc1)ccc1OC[C@H](CN(/C(/I)=C(/CO)\N)N)O)c(cc1)cc(C)c1OC[C@H](CCl)O Chemical compound CC(C)(c(cc1)ccc1OC[C@H](CN(/C(/I)=C(/CO)\N)N)O)c(cc1)cc(C)c1OC[C@H](CCl)O XIAWGUMGQWOVAE-FHXNKAKFSA-N 0.000 description 1
- FGARZMQDXVQNRR-PKTZIBPZSA-N CC(C)(c(cc1)ccc1OC[C@H](CN1CCOCC1)O)c(cc1C)ccc1OC[C@@H](CCl)O Chemical compound CC(C)(c(cc1)ccc1OC[C@H](CN1CCOCC1)O)c(cc1C)ccc1OC[C@@H](CCl)O FGARZMQDXVQNRR-PKTZIBPZSA-N 0.000 description 1
- QAGKXUTUMYBUHG-PKTZIBPZSA-N CC(C)(c(cc1)ccc1OC[C@H](CN1CCSCC1)O)c(cc1)cc(C)c1OC[C@@H](CCl)O Chemical compound CC(C)(c(cc1)ccc1OC[C@H](CN1CCSCC1)O)c(cc1)cc(C)c1OC[C@@H](CCl)O QAGKXUTUMYBUHG-PKTZIBPZSA-N 0.000 description 1
- QAGKXUTUMYBUHG-GOTSBHOMSA-N CC(C)(c(cc1)ccc1OC[C@H](CN1CCSCC1)O)c(cc1)cc(C)c1OC[C@H](CCl)O Chemical compound CC(C)(c(cc1)ccc1OC[C@H](CN1CCSCC1)O)c(cc1)cc(C)c1OC[C@H](CCl)O QAGKXUTUMYBUHG-GOTSBHOMSA-N 0.000 description 1
- JGVVSLFUPPJXSW-PMACEKPBSA-N CC(C)(c(cc1)ccc1OC[C@H](CN1NNC=C1CO)O)c(cc1)cc(I)c1OC[C@H](CCl)O Chemical compound CC(C)(c(cc1)ccc1OC[C@H](CN1NNC=C1CO)O)c(cc1)cc(I)c1OC[C@H](CCl)O JGVVSLFUPPJXSW-PMACEKPBSA-N 0.000 description 1
- NUMVCFPEPFMVBX-BZZOAKBMSA-N CC(C)(c1ccc(COCC(CN(/C(/I)=C(/CO)\N)N)O)cc1)c(cc1C)ccc1OCC(CCl)O Chemical compound CC(C)(c1ccc(COCC(CN(/C(/I)=C(/CO)\N)N)O)cc1)c(cc1C)ccc1OCC(CCl)O NUMVCFPEPFMVBX-BZZOAKBMSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562102719P | 2015-01-13 | 2015-01-13 | |
| US62/102,719 | 2015-01-13 | ||
| PCT/CA2016/000008 WO2016112455A1 (en) | 2015-01-13 | 2016-01-13 | Heterocyclic compounds for cancer imaging and treatment and methods for their use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021009453A Division JP2021073248A (ja) | 2015-01-13 | 2021-01-25 | がんの画像化及び治療用のヘテロ環式化合物ならびにそれらの使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018502867A JP2018502867A (ja) | 2018-02-01 |
| JP2018502867A5 true JP2018502867A5 (https=) | 2019-02-21 |
| JP6884100B2 JP6884100B2 (ja) | 2021-06-09 |
Family
ID=56405073
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017536829A Expired - Fee Related JP6884100B2 (ja) | 2015-01-13 | 2016-01-13 | がんの画像化及び治療用のヘテロ環式化合物ならびにそれらの使用方法 |
| JP2021009453A Withdrawn JP2021073248A (ja) | 2015-01-13 | 2021-01-25 | がんの画像化及び治療用のヘテロ環式化合物ならびにそれらの使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021009453A Withdrawn JP2021073248A (ja) | 2015-01-13 | 2021-01-25 | がんの画像化及び治療用のヘテロ環式化合物ならびにそれらの使用方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US10654811B2 (https=) |
| EP (3) | EP3245193B1 (https=) |
| JP (2) | JP6884100B2 (https=) |
| AU (2) | AU2016206412B2 (https=) |
| CA (1) | CA2973036C (https=) |
| DK (2) | DK3245193T3 (https=) |
| ES (2) | ES2907708T3 (https=) |
| FI (1) | FI3988541T3 (https=) |
| HU (1) | HUE057962T2 (https=) |
| IL (2) | IL253394B (https=) |
| NZ (1) | NZ733343A (https=) |
| PL (1) | PL3988541T3 (https=) |
| PT (1) | PT3988541T (https=) |
| WO (1) | WO2016112455A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2572596C2 (ru) | 2008-07-02 | 2016-01-20 | Бритиш Коламбиа Кэнсер Эйдженси Бранч | Терапевтические средства на основе производных диглицилиловых простых эфиров и способы их применения |
| JP6884100B2 (ja) | 2015-01-13 | 2021-06-09 | ブリティッシュ コロンビア キャンサー エージェンシー ブランチ | がんの画像化及び治療用のヘテロ環式化合物ならびにそれらの使用方法 |
| US10471023B2 (en) | 2015-03-12 | 2019-11-12 | British Columbia Cancer Agency Branch | Bisphenol ether derivatives and methods for using the same |
| US20170298033A1 (en) | 2016-04-15 | 2017-10-19 | The University Of British Columbia | Bisphenol derivatives and their use as androgen receptor activity modulators |
| CN107337612B (zh) * | 2017-06-15 | 2019-06-18 | 杭州科兴生物化工有限公司 | 双酚类化合物及其制备方法和在制备抗肿瘤药物中的应用 |
| CN109772352B (zh) * | 2017-11-14 | 2021-08-31 | 中国石油化工股份有限公司 | 一种制备1,4-丁炔二醇联产丙炔醇的催化剂及其制备方法和应用 |
| WO2019226991A1 (en) | 2018-05-25 | 2019-11-28 | Essa Pharma, Inc. | Androgen receptor modulators and methods for their use |
| MX2021004427A (es) | 2018-10-18 | 2021-11-12 | Univ British Columbia | Moduladores del receptor de andrógenos y métodos para su uso. |
| WO2020198712A1 (en) | 2019-03-28 | 2020-10-01 | Essa Pharma, Inc. | Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof |
| CN114502539A (zh) * | 2019-03-28 | 2022-05-13 | 埃萨制药股份有限公司 | 包含雄激素受体的抑制剂的药物组合物和组合及其用途 |
| AU2020247255A1 (en) * | 2019-03-28 | 2021-11-11 | Essa Pharma, Inc. | Androgen receptor modulators and methods for use as Proteolysis Targeting Chimera ligands |
| AU2021255723A1 (en) | 2020-04-17 | 2022-12-08 | Essa Pharma, Inc. | Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof |
| WO2022060969A1 (en) * | 2020-09-16 | 2022-03-24 | Essa Pharma, Inc. | Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof |
| WO2022221661A1 (en) * | 2021-04-16 | 2022-10-20 | Essa Pharma, Inc. | Pharmaceutical compositions comprising inhibitors of the androgen receptor and uses thereof |
| WO2023046283A1 (en) | 2021-09-22 | 2023-03-30 | Fundació Institut De Recerca Biomèdica (Irb Barcelona) | Compounds and their use in a method for modulating ar (androgen receptor) transcriptional activity |
| WO2025034663A2 (en) * | 2023-08-04 | 2025-02-13 | The General Hospital Corporation | Differentiation of patients with and without prostate cancer using urine 1h nmr metabolomics |
Family Cites Families (81)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2571217A (en) | 1951-10-16 | Horace s | ||
| US2890189A (en) | 1954-06-14 | 1959-06-09 | Johnson & Son Inc S C | Alkali soluble resins and compositions containing the same |
| US3074974A (en) | 1957-12-06 | 1963-01-22 | Monsanto Chemicals | Method for the preparation of diglycidyl ether of tetrachlorobisphenol-a |
| US3162615A (en) | 1961-01-03 | 1964-12-22 | Dow Chemical Co | Polyesters from cyclic polyhaloalkane polyols and unsaturated dicarboxylic acids |
| FR1389005A (fr) | 1963-01-09 | 1965-02-12 | Bayer Ag | Procédé perfectionné pour durcir des polyépoxydes |
| SU638596A1 (ru) * | 1975-09-01 | 1978-12-25 | Государственный Научно-Исследовательский И Проектный Институт Полимерных Клеев Им. Э.Л.Тер-Газаряна | Хлоргидриднное производное диаллилизоциануровой кислоты в качестве пластификатора поливинилацетатной эмульсии |
| US4284574A (en) | 1979-06-15 | 1981-08-18 | Ciba-Geigy Corporation | Diglycidyl ethers of di-secondary alcohols, their preparation, and curable compositions containing them |
| SU929630A1 (ru) | 1980-02-06 | 1982-05-23 | Научно-Исследовательский Институт Биологии При Иркутском Государственном Университете Им.А.А.Жданова | Способ получени ди-или триоксидифенил-сульфонов |
| US4369298A (en) | 1980-05-27 | 1983-01-18 | Tokuyama Soda Kabushiki Kaisha | Novel cured resin, process for production thereof, and lens composed of said resin from bis(alkyleneoxyphenyl)-diacrylate, bis(alkyleneoxyphenyl)diallyl ether, bis(alkyleneoxyphenyl)diallyl carbonate monomers |
| EP0056175B1 (en) | 1981-01-13 | 1985-05-02 | Teijin Limited | Ion-permeable composite membrane and its use in selective separation |
| IN169231B (https=) | 1984-03-15 | 1991-09-14 | Ciba Geigy Ag | |
| PL141793B1 (en) | 1984-10-08 | 1987-08-31 | Politechnika Warszawska | Method of obtaining bisphenolic resins |
| US5753730A (en) | 1986-12-15 | 1998-05-19 | Mitsui Toatsu Chemicals, Inc. | Plastic lenses having a high-refractive index, process for the preparation thereof and casting polymerization process for preparing sulfur-containing urethane resin lens and lens prepared thereby |
| JPH0832844B2 (ja) | 1987-02-09 | 1996-03-29 | パイロツトインキ株式会社 | 筆記板用不透明性インキ |
| DE3852839T2 (de) | 1987-04-27 | 1995-06-22 | Mitsubishi Gas Chemical Co | Hitzehärtbare Harzzusammensetzung. |
| WO1988009782A1 (en) | 1987-06-01 | 1988-12-15 | The Dow Chemical Company | Process for making propargyl ethers of hydroxyaromatic compounds |
| US5155196A (en) | 1987-06-01 | 1992-10-13 | The Dow Chemical Company | Polymer resulting from the cure of a preformed chromene-containing mixture |
| JP2572020B2 (ja) | 1987-06-19 | 1997-01-16 | 竹本油脂株式会社 | 熱硬化性樹脂用難燃剤 |
| DE3821585A1 (de) | 1987-09-13 | 1989-03-23 | Hoechst Ag | Positiv arbeitendes strahlungsempfindliches gemisch und daraus hergestelltes strahlungsempfindliches aufzeichnungsmaterial fuer hochenergetische strahlung |
| US4855184A (en) | 1988-02-02 | 1989-08-08 | Minnesota Mining And Manufacturing Company | Radiation-curable protective coating composition |
| DE3939760A1 (de) | 1989-12-01 | 1991-06-06 | Bayer Ag | Verfahren zur lackierung von kunststoffen, lackierte kunststoffe und die verwendung von hierzu geeigneten haftvermittlern |
| EP0515128A1 (en) | 1991-05-23 | 1992-11-25 | Konica Corporation | Silver halide color photographic light-sensitive material |
| JPH0649473A (ja) | 1992-08-04 | 1994-02-22 | Asahi Chem Ind Co Ltd | 冷媒組成物 |
| DE4323512A1 (de) | 1992-09-01 | 1994-04-28 | Agfa Gevaert Ag | Fotografisches Aufzeichnungsmaterial |
| JPH07117349A (ja) | 1993-10-27 | 1995-05-09 | Asahi Denka Kogyo Kk | 感熱記録材料 |
| CN1167437A (zh) | 1994-11-29 | 1997-12-10 | 赫彻斯特马里恩鲁斯公司 | 用三芳基-乙烯衍生物治疗和预防骨质疏松的方法 |
| DE19526146A1 (de) | 1995-07-07 | 1997-01-09 | Schering Ag | Triphenylethylene, Verfahren zu deren Herstellung, diese Triphenylethylene enthaltene pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln |
| JPH09176240A (ja) | 1995-12-27 | 1997-07-08 | Mitsubishi Chem Corp | 光重合性組成物 |
| JPH10133427A (ja) | 1996-11-05 | 1998-05-22 | Fuji Xerox Co Ltd | 静電潜像現像用キャリア、静電潜像現像剤及び画像形成方法 |
| ZA98900B (en) | 1997-02-07 | 1998-08-03 | Shell Int Research | Process for the manufacture of epoxy compounds |
| JPH10316803A (ja) | 1997-05-16 | 1998-12-02 | Teijin Chem Ltd | 難燃性樹脂組成物 |
| IL125840A (en) | 1997-08-22 | 2002-12-01 | Teijin Chemicals Ltd | Bromine compound production method |
| JPH11166087A (ja) | 1997-12-04 | 1999-06-22 | Teijin Chem Ltd | 難燃性樹脂組成物 |
| AU4494399A (en) | 1998-06-30 | 2000-01-24 | University Of British Columbia, The | Inhibitors of androgen-independent activation of androgen receptor |
| US6245117B1 (en) | 1998-08-07 | 2001-06-12 | Ipposha Oil Industries Co., Ltd. | Modifier of cellulose fibers and modification method of cellulose fibers |
| US6218430B1 (en) | 1998-08-24 | 2001-04-17 | Ligand Pharmaceuticals Incorporated | Vitamin D3 mimics |
| JP3795679B2 (ja) | 1998-09-01 | 2006-07-12 | 帝人化成株式会社 | 臭素化合物の製造方法 |
| AU775928B2 (en) | 1999-10-14 | 2004-08-19 | Bristol-Myers Squibb Company | Crystallographic structure of the androgen receptor ligand binding domain |
| US6534621B2 (en) | 2000-05-18 | 2003-03-18 | Dow Global Technologies Inc. | Process for manufacturing a hydroxyester derivative intermediate and epoxy resins prepared therefrom |
| US6472436B1 (en) | 2000-07-17 | 2002-10-29 | The Salk Institute For Biological Studies | Methods for protecting cells from amyloid toxicity and for inhibiting amyloid protein production |
| US6756400B2 (en) | 2000-08-31 | 2004-06-29 | Theravance, Inc. | Sodium channel modulators |
| US6646102B2 (en) | 2001-07-05 | 2003-11-11 | Dow Global Technologies Inc. | Process for manufacturing an alpha-dihydroxy derivative and epoxy resins prepared therefrom |
| US20030092724A1 (en) | 2001-09-18 | 2003-05-15 | Huaihung Kao | Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic |
| US7344700B2 (en) | 2002-02-28 | 2008-03-18 | University Of Tennessee Research Corporation | Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy |
| GB0324551D0 (en) | 2003-10-21 | 2003-11-26 | Karobio Ab | Novel compounds |
| US7595345B2 (en) | 2003-11-20 | 2009-09-29 | Eli Lilly And Company | Vitamin D receptor modulators |
| CA2555597C (en) | 2004-02-13 | 2016-06-14 | The University Of British Columbia | Radiolabeled compounds and compositions, their precursors and methods for their production |
| JP2005325301A (ja) | 2004-05-17 | 2005-11-24 | Fuji Photo Film Co Ltd | セルロースアシレートドープ組成物、およびセルロースアシレートフィルム |
| EP1781280A2 (en) | 2004-08-18 | 2007-05-09 | Warner-Lambert Company LLC | Androgen modulators |
| JP2006208607A (ja) | 2005-01-26 | 2006-08-10 | Fuji Photo Film Co Ltd | パターン形成材料、並びにパターン形成装置及び永久パターン形成方法 |
| JP4753601B2 (ja) | 2005-03-23 | 2011-08-24 | 旭化成イーマテリアルズ株式会社 | 感光性組成物 |
| EP1717235A3 (en) | 2005-04-29 | 2007-02-28 | Bioprojet | Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands |
| FR2885904B1 (fr) | 2005-05-19 | 2007-07-06 | Aventis Pharma Sa | Nouveaux derives du fluorene, compositions les contenant et utilisation |
| EP1792622A1 (en) | 2005-11-11 | 2007-06-06 | GPC Biotech AG | Anti-proliferative combination therapy comprising a platinum-based chemotherapeutic agent and EGFR inhibitors or pyrimidine analogues |
| JP2007290980A (ja) | 2006-04-21 | 2007-11-08 | Shin Etsu Chem Co Ltd | 含フッ素（メタ）アクリル酸エステル |
| DE102006019044A1 (de) | 2006-04-25 | 2007-10-31 | Merck Patent Gmbh | Antioxidantien |
| TW200819421A (en) | 2006-10-31 | 2008-05-01 | Univ Nat Chunghsing | The method of synthesizing biphenol A, BPA having di-alkoxyl group by using polycarbonate or its waste |
| KR20090115797A (ko) | 2007-02-20 | 2009-11-06 | 바스프 에스이 | 고굴절률 단량체, 이의 조성물 및 용도 |
| RU2572596C2 (ru) | 2008-07-02 | 2016-01-20 | Бритиш Коламбиа Кэнсер Эйдженси Бранч | Терапевтические средства на основе производных диглицилиловых простых эфиров и способы их применения |
| AU2009279936A1 (en) | 2008-08-05 | 2010-02-11 | Banyu Pharmaceutical Co., Ltd. | Therapeutic compounds |
| AR079975A1 (es) | 2010-01-06 | 2012-03-07 | British Columbia Cancer Agency | Agentes terapeuticos derivados de bisfenol u metodos para su uso, composiciones farmaceuticas y uso de los mismos |
| AR079846A1 (es) | 2010-01-06 | 2012-02-22 | British Columbia Cancer Agency | Agentes terapeuticos derivados de bisfenol que contienen un grupo aquiral y su uso en el tratamiento del cancer |
| EP2693875A4 (en) | 2011-04-08 | 2014-10-22 | British Columbia Cancer Agency | BISPHENOL COMPOUNDS AND METHOD FOR THEIR USE |
| WO2012145328A1 (en) | 2011-04-18 | 2012-10-26 | The University Of British Columbia | Dibenzylphenyl compounds and methods for their use |
| WO2012145330A1 (en) | 2011-04-18 | 2012-10-26 | The University Of British Columbia | Fluorene-9-bisphenol compounds and methods for their use |
| WO2013028572A1 (en) | 2011-08-19 | 2013-02-28 | British Columbia Cancer Agency Branch | Fluorinated bisphenol ether compounds and methods for their use |
| WO2013028791A1 (en) | 2011-08-22 | 2013-02-28 | British Columbia Cancer Agency Branch | 18f compounds for cancer imaging and methods for their use |
| US9365510B2 (en) | 2012-04-16 | 2016-06-14 | British Columbia Cancer Agency Branch | Aziridine bisphenol ethers and related compounds and methods for their use |
| CN105358522A (zh) | 2013-05-10 | 2016-02-24 | 不列颠哥伦比亚癌症局分支机构 | 雄激素受体调节剂的酯衍生物及其使用方法 |
| CN103342892A (zh) | 2013-06-06 | 2013-10-09 | 西安交通大学 | 一种双马来酰亚胺树脂的增韧改性剂及其制备方法 |
| US20150010469A1 (en) | 2013-07-03 | 2015-01-08 | British Columbia Cancer Agency Branch | Bisphenol ether compounds with novel bridging groups and methods for their use |
| SG11201601431VA (en) | 2013-09-09 | 2016-03-30 | British Columbia Cancer Agency | Halogenated compounds for cancer imaging and treatment and methods for their use |
| WO2016058082A1 (en) | 2014-10-14 | 2016-04-21 | British Columbia Cancer Agency Branch | 18f compounds for cancer imaging and methods for their use |
| WO2016058080A1 (en) | 2014-10-14 | 2016-04-21 | British Columbia Cancer Agency Branch | Fluoro-chloro bisphenol ether compounds and methods for their use |
| JP6884100B2 (ja) | 2015-01-13 | 2021-06-09 | ブリティッシュ コロンビア キャンサー エージェンシー ブランチ | がんの画像化及び治療用のヘテロ環式化合物ならびにそれらの使用方法 |
| US10471023B2 (en) | 2015-03-12 | 2019-11-12 | British Columbia Cancer Agency Branch | Bisphenol ether derivatives and methods for using the same |
| CA2929345A1 (en) | 2015-09-02 | 2017-03-02 | British Columbia Cancer Agency Branch | Co-targeting androgen receptor splice variants and mtor signaling pathway for the treatment of castration-resistant prostate cancer |
| US20170298033A1 (en) | 2016-04-15 | 2017-10-19 | The University Of British Columbia | Bisphenol derivatives and their use as androgen receptor activity modulators |
| WO2017210771A1 (en) | 2016-06-06 | 2017-12-14 | British Columbia Cancer Agency Branch | Compounds and compositions for radiation therapy and methods of using the same |
| WO2019226991A1 (en) * | 2018-05-25 | 2019-11-28 | Essa Pharma, Inc. | Androgen receptor modulators and methods for their use |
| MX2021004427A (es) | 2018-10-18 | 2021-11-12 | Univ British Columbia | Moduladores del receptor de andrógenos y métodos para su uso. |
-
2016
- 2016-01-13 JP JP2017536829A patent/JP6884100B2/ja not_active Expired - Fee Related
- 2016-01-13 ES ES16736999T patent/ES2907708T3/es active Active
- 2016-01-13 PL PL21212648.6T patent/PL3988541T3/pl unknown
- 2016-01-13 DK DK16736999.0T patent/DK3245193T3/da active
- 2016-01-13 PT PT212126486T patent/PT3988541T/pt unknown
- 2016-01-13 FI FIEP21212648.6T patent/FI3988541T3/fi active
- 2016-01-13 EP EP16736999.0A patent/EP3245193B1/en active Active
- 2016-01-13 WO PCT/CA2016/000008 patent/WO2016112455A1/en not_active Ceased
- 2016-01-13 ES ES21212648T patent/ES2987829T3/es active Active
- 2016-01-13 DK DK21212648.6T patent/DK3988541T3/da active
- 2016-01-13 NZ NZ733343A patent/NZ733343A/en unknown
- 2016-01-13 EP EP24184079.2A patent/EP4446301A3/en not_active Withdrawn
- 2016-01-13 CA CA2973036A patent/CA2973036C/en active Active
- 2016-01-13 US US15/543,389 patent/US10654811B2/en active Active
- 2016-01-13 EP EP21212648.6A patent/EP3988541B1/en active Active
- 2016-01-13 HU HUE16736999A patent/HUE057962T2/hu unknown
- 2016-01-13 AU AU2016206412A patent/AU2016206412B2/en not_active Ceased
-
2017
- 2017-07-10 IL IL253394A patent/IL253394B/en active IP Right Grant
-
2020
- 2020-05-01 US US16/864,479 patent/US11345670B2/en active Active
- 2020-09-14 AU AU2020233630A patent/AU2020233630B2/en not_active Ceased
-
2021
- 2021-01-25 JP JP2021009453A patent/JP2021073248A/ja not_active Withdrawn
- 2021-02-16 IL IL280899A patent/IL280899B/en unknown
-
2022
- 2022-04-26 US US17/729,780 patent/US20220267283A1/en not_active Abandoned
-
2024
- 2024-08-01 US US18/791,751 patent/US20240391883A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018502867A5 (https=) | ||
| JP2019513795A5 (https=) | ||
| ES2812800T3 (es) | Nuevos usos terapéuticos de derivados de la bencilidenguanidina para el tratamiento de proteopatías | |
| AU2020305979B2 (en) | Method for treating idiopathic pulmonary fibrosis | |
| JP7142577B2 (ja) | ビスフェノール誘導体、及びアンドロゲン受容体活性調節因子としてのそれらの使用 | |
| CA2973036C (en) | HETEROCYCLIC COMPOUNDS FOR CANCER IMAGING AND TREATMENT AND THEIR METHODS OF USE | |
| JP2006515859A5 (https=) | ||
| JP2016513661A5 (https=) | ||
| JP2018521017A5 (https=) | ||
| JP6357292B2 (ja) | Ｃｎｋｓｒ１を阻害するための方法及び組成物 | |
| US20180064657A1 (en) | Bisphenol ether derivatives and methods for using the same | |
| BR112018069930B1 (pt) | Compostos agonistas de ppar, uso dos mesmos e composição farmacêutica | |
| JP2014506582A5 (https=) | ||
| AU2019258078B2 (en) | 10H-phenothiazine ferroptosis inhibitor and preparation method therefor and application thereof | |
| JP2017516862A5 (https=) | ||
| US11104651B2 (en) | PERK inhibitors and uses thereof in treating diseases associated with aggregation-prone proteins | |
| AU2014262764B2 (en) | Radiomitigating pharmaceutical formulations | |
| JP2021522327A5 (https=) | ||
| ES2346323T3 (es) | Bencimidazoles sustituidos y su uso para inducir apoptosis. | |
| EA028063B1 (ru) | N-[4-(хинолин-4-илокси)циклогексил(метил)](гетеро)арилкарбоксамиды в качестве антагонистов андрогенного рецептора, их получение и применение в качестве лекарственных средств | |
| WO2024189592A9 (en) | Sephin1 and related compounds for the treatment of diseases and disorders amenable to treatment by ampk activation and/or chop inhibition | |
| JPWO2018186366A1 (ja) | 新規サイクリン依存性キナーゼ８及び／又は１９阻害剤 | |
| CA3213275A1 (en) | A combination comprising a specific hdac6 inhibitor and at least one ctla4 checkpoint inhibitor | |
| US9980936B2 (en) | BH4 antagonists and methods related thereto | |
| EP4552642A1 (en) | Agent for reducing blood myostatin level |